-Down to Earth The free medicine scheme in Rajasthan may benefit Congress Of the many poll sops that Rajasthan Chief Minister Ashok Gehlot doled out in the past two years, the one scheme that seems to have struck the right chord with voters is the initiative to give free essential medicines at government healthcare facilities. The Mukhyamantri Nishulk Dava Yojna, launched in 2011, has offered some hope to the incumbent Congress government,...

-Down to Earth Expresses concern over alcohol brands being advertised in violation of rules India is emerging as the favourite destination for alcohol promotion of marketing companies. Their new targets are women and youth, who at present comprise a very small percentage of alcohol consumers in India. These are the observations made by a report-Alcohol Marketing and Regulatory Policy Environment in India-put out by the Public Health Foundation of India (PHFI). It...

-The Hindu Unless a deeper, institutional change is ushered in to break the nexus between drug companies and the regulatory regime, Indians consuming drugs may be exposing themselves to serious risks Even before I walked into the Mayflower Hotel in the heart of Washington on a crisp autumn afternoon to meet Dinesh Thakur, whistle-blower and former director of India-based pharmaceutical giant Ranbaxy, I had a hunch that this conversation would spark some...

-The United Nations Treatment has saved the lives of more than 22 million people with tuberculosis (TB), according to a new report by the United Nations health agency that also reveals that the number of deaths from the disease fell to 1.3 million last year. The Global Tuberculosis Report 2013, published today by the World Health Organization (WHO), confirms that the world is on track to meet the Millennium Development Goals (MDGs)...

-The Economic Times The government must explain to the Supreme Court, with scientific evidence, why the pentavalent vaccine, now introduced into the immunisation programme, should not be banned. The vaccine is designed to combat five childhood diseases: diphtheria, pertussis, tetanus, Hepatitis B, pneumonia and meningitis. So far, more than 82,000 doses have been administered and there have been 29 cases of adverse effects after immunisation. After examining the evidence, it is unclear...